According to the announcement by Pharming Group N.V., the company will take part in the Oppenheimer Movers in Rare Disease Summit on December 11, 2025, in New York. This event, which is by invitation only, brings together innovative companies and investors focused on rare diseases.
Keynote Speech
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Anurag Relan, M.D., Chief Medical Officer of Pharming, will participate in an informal discussion focused on the market for Hereditary Angioedema (HAE) at 1:50 PM Eastern Time (7:50 PM CET).
Scheduling Individual Meetings
To arrange a one-on-one meeting with the Pharming management team, interested parties are invited to contact the investor relations via the provided email address or through their Oppenheimer representative.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
